(Total Views: 346)
Posted On: 04/24/2018 1:42:15 PM
Post# of 72446
I agree that taking B-OM to market ourselves would be a relatively simple (and rewarding) undertaking that I would wholeheartedly support for several reasons.
1) Announcing and demonstrating that we are serious about going it alone with B-OM will motivate potential suitors.
2) The profit margin would be VERY substantial so selling B-OM direct means significant income which would negate the need for additional dilution to fund operations and drug development.
3) The market values biotech’s that are producing significant revenues much differently than it values pre-revenue biotechs so our FUDster friends would find it harder to keep our share price down.
“i'd love to see the company say F-U to the prospective partners, and market Bril-OM itself.” - Drano
1) Announcing and demonstrating that we are serious about going it alone with B-OM will motivate potential suitors.
2) The profit margin would be VERY substantial so selling B-OM direct means significant income which would negate the need for additional dilution to fund operations and drug development.
3) The market values biotech’s that are producing significant revenues much differently than it values pre-revenue biotechs so our FUDster friends would find it harder to keep our share price down.
“i'd love to see the company say F-U to the prospective partners, and market Bril-OM itself.” - Drano
(4)
(0)
